BIAF
bioAffinity Technologies, Inc.
$1.48
-9.20%
$6.7M
No data for this timeframe.
Vol
Market Cap$6.7M
Cap SizeNano Cap
Inst. Holders5 funds
Inst. Value$387.1K
Inst. Activity0 buys / 1 sells
Reddit Sentiment60° Warm
SEC Reports3
Exchange Nasdaq·Sector Services-Commercial Physical & Biological Research·Inc. DE·CIK 0001712762·Prev Close $1.63
Recent Activity
Jun 12, 2026
SEC
bioAffinity Technologies filed an S-1 registration statement for a best-efforts public offering of up to 2,631,579 share
S-1 — Impact 6/10
May 20, 2026
earnings_calendar
BIAF Q1 2026 Earnings Scheduled — 2026-05-20
Mar 3, 2026
SEC
BioAffinity Technologies, Inc. announced the presentation of a scientific poster at the American Academy of Allergy, Ast
8-K — Impact 3/10
Feb 25, 2026
SEC
bioAffinity Technologies announced a new clinical study with Brooke Army Medical Center to validate the use of its CyPat
8-K — Impact 4/10
Inst.
BANK OF AMERICA CORP — NEAR_EXIT
38 shares ($45.00)
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 1, 2025 | Maxim Group | DOWNGRADE | Buy → Hold |
| Jul 23, 2024 | Maxim Group | INITIATE | Buy |
Latest Reports
BEARISH
S-1
6/10
bioAffinity Technologies filed an S-1 registration statement for a best-efforts public offering of up to 2,631,579 share
Jun 12, 2026
NEUTRAL
8-K
3/10
BioAffinity Technologies, Inc. announced the presentation of a scientific poster at the American Academy of Allergy, Ast
Mar 3, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $212.7K | — |
| VANGUARD FIDUCIARY TRUST CO | $119.0K | — |
| STATE STREET CORP | $55.1K | — |
| CITIGROUP INC | $218.00 | — |
| MORGAN STANLEY | $11.00 | — |
Reddit Sentiment
60°
Warm
Bearish
Neutral
Bullish
5 institutional holders with $387.1K total value (101,060 shares) as of 2026-Q1. Top holders: VANGUARD, VANGUARD, STATE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 55,543 | $212.7K | 55.0% | — |
| 2 | VANGUARD FIDUCIARY TRUST CO | 31,071 | $119.0K | 30.7% | — |
| 3 | STATE STREET CORP | 14,386 | $55.1K | 14.2% | — |
| 4 | CITIGROUP INC | 57 | $218.00 | 0.1% | — |
| 5 | MORGAN STANLEY | 3 | $11.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 1,684 | 38 | -97.7% | $45.00 | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 4.3/10.
BEARISH
S-1
6/10
bioAffinity Technologies filed an S-1 registration statement for a best-efforts public offering of u
Jun 12, 2026
NEUTRAL
8-K
3/10
BioAffinity Technologies, Inc. announced the presentation of a scientific poster at the American Aca
Mar 3, 2026
NEUTRAL
8-K
4/10
bioAffinity Technologies announced a new clinical study with Brooke Army Medical Center to validate
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Apr 2025): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 1, 2025 | Maxim Group | DOWNGRADE | Buy | Hold |
| Jul 23, 2024 | Maxim Group | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Dec 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
60°
Warm
Bearish
Neutral
Bullish
11 mentions
3 bullish
0 bearish
11 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Mar 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 19, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 19, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 18, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
BIAF, run for the exits, this is going down the tube.
▲ 1
💬 0
⚡ 0.5
$BIAF STOCK
▲ 1
💬 1
⚡ 0.5
BIAF jumped 40% yesterday
▲ 1
💬 0
⚡ 0.5
Why did BIAF surge over 40% yesterday?
▲ 1
💬 1
⚡ 0.5
May 20, 2026
earnings_calendar
BIAF Q1 2026 Earnings Scheduled — 2026-05-20
Apr 28, 2026
short_volume
Short Volume: BIAF — 59.5% short (1.0M / 1.6M)
Short: 980,379 | Exempt: 3,878 | TRF Vol: 1,648,572 | Short Ratio: 59.5% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
earnings_calendar
BIAF Q4 2025 Earnings Scheduled — 2026-04-06
Apr 2, 2026
short_interest
FTD: BIAF — 245,411 shares ($1.0M) failed to deliver
Settlement: 20260402, Price: $3.98, FTD Value: $976,735.78, BIOAFFINITY TECHNOLOGIES INC C
Apr 2, 2026
short_volume
Short Volume: BIAF — 58.1% short (0.5M / 0.8M)
Short: 450,294 | Exempt: 1,006 | TRF Vol: 775,572 | Short Ratio: 58.1% | Off-exchange volume (dark pool + OTC)
Apr 1, 2026
short_volume
Short Volume: BIAF — 60.4% short (2.3M / 3.8M)
Short: 2,320,366 | Exempt: 41,660 | TRF Vol: 3,842,454 | Short Ratio: 60.4% | Off-exchange volume (dark pool + OTC)
Mar 31, 2026
short_volume
Short Volume: BIAF — 66.5% short (0.4M / 0.5M)
Short: 362,203 | Exempt: 92,907 | TRF Vol: 544,520 | Short Ratio: 66.5% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
short_volume
Short Volume: BIAF — 58.8% short (0.4M / 0.7M)
Short: 410,192 | Exempt: 101,870 | TRF Vol: 697,974 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
short_interest
FTD: BIAF — 268,093 shares ($1.1M) failed to deliver
Settlement: 20260326, Price: $3.97, FTD Value: $1,064,329.21, BIOAFFINITY TECHNOLOGIES INC C
Mar 26, 2026
short_volume
Short Volume: BIAF — 58.2% short (1.5M / 2.6M)
Short: 1,536,465 | Exempt: 14,013 | TRF Vol: 2,639,174 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_volume
Short Volume: BIAF — 58.6% short (3.2M / 5.4M)
Short: 3,185,605 | Exempt: 582,447 | TRF Vol: 5,439,107 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
short_interest
FTD: BIAF — 287,666 shares ($0.8M) failed to deliver
Settlement: 20260323, Price: $2.73, FTD Value: $785,328.18, BIOAFFINITY TECHNOLOGIES INC C
Mar 19, 2026
short_interest
FTD: BIAF — 227,030 shares ($0.6M) failed to deliver
Settlement: 20260319, Price: $2.43, FTD Value: $551,682.9, BIOAFFINITY TECHNOLOGIES INC C
Mar 18, 2026
short_interest
FTD: BIAF — 919,903 shares ($2.5M) failed to deliver
Settlement: 20260318, Price: $2.74, FTD Value: $2,520,534.22, BIOAFFINITY TECHNOLOGIES INC C
Mar 17, 2026
short_interest
FTD: BIAF — 894,376 shares ($1.7M) failed to deliver
Settlement: 20260317, Price: $1.91, FTD Value: $1,708,258.16, BIOAFFINITY TECHNOLOGIES INC C